Abstract
Purpose
We evaluated the impact of examined lymph node (ELN) number on the prognosis of stage II colon cancer after radical surgery and developed a novel prognostic scoring system by combining primary tumor extension (pT) and ELN number for reclassification of stage II colon cancer.
Methods
Three cohorts of patients diagnosed with colon cancer between 2004 and 2010 were identified from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate analyses were performed to evaluate the relationship between factors and patients’ survival including cause-specific survival (CSS) and overall survival (OS). Survival curves from subgroups were plotted by the Kaplan-Meier method and compared by the log-rank test.
Results
Cohort 1 and cohort 2 consisted of 13,960 and 5312 stage II colon cancer patients, respectively. Cohort 3 consisted of 4713 stage III patients. Factors including ELN, age, and pT were found to be associated with patients’ survival in cohorts 1 and 2. Patients who were older or with smaller tumors were more likely to experience inadequate ELN. Patients with a higher score, as calculated by the novel scoring system, showed worse survival. Compared with stage III colon cancer patients, stage II patients with high scores had a comparable or even worse survival than stage IIIA and IIIB patients.
Conclusion
Inadequate ELN leads to understaging in stage II colon cancer and predicts inferior prognosis. Our analyses show that the novel prognostic scoring system, consisting of combined pT and ELN, quantified stage migration effect and can be applied to the reclassification of stage II colon cancer.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00384-020-03794-6/MediaObjects/384_2020_3794_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00384-020-03794-6/MediaObjects/384_2020_3794_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00384-020-03794-6/MediaObjects/384_2020_3794_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00384-020-03794-6/MediaObjects/384_2020_3794_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00384-020-03794-6/MediaObjects/384_2020_3794_Fig5_HTML.png)
Similar content being viewed by others
Data availability
The data sets used and/or analyzed during the current study are available from the SEER database.
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, Jemal A (2017) Colorectal cancer statistics, 2017. CA Cancer J Clin 67(3):177–193. https://doi.org/10.3322/caac.21395
Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, Nordlinger B, van de Velde CJ, Balmana J, Regula J, Nagtegaal ID, Beets-Tan RG, Arnold D, Ciardiello F, Hoff P, Kerr D, Köhne CH, Labianca R, Price T, Scheithauer W, Sobrero A, Tabernero J, Aderka D, Barroso S, Bodoky G, Douillard JY, El Ghazaly H, Gallardo J, Garin A, Glynne-Jones R, Jordan K, Meshcheryakov A, Papamichail D, Pfeiffer P, Souglakos I, Turhal S, Cervantes A (2012) ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol 23(10):2479–2516. https://doi.org/10.1093/annonc/mds236
Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kinugasa Y, Murofushi K, Nakajima TE, Oka S, Tanaka T, Taniguchi H, Tsuji A, Uehara K, Ueno H, Yamanaka T, Yamazaki K, Yoshida M, Yoshino T, Itabashi M, Sakamaki K, Sano K, Shimada Y, Tanaka S, Uetake H, Yamaguchi S, Yamaguchi N, Kobayashi H, Matsuda K, Kotake K, Sugihara K (2020) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25(1):1–42. https://doi.org/10.1007/s10147-019-01485-z
O'Connor ES, Greenblatt DY, LoConte NK, Gangnon RE, Liou JI, Heise CP, Smith MA (2011) Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. J Clin Oncol 29(25):3381–3388. https://doi.org/10.1200/jco.2010.34.3426
Gkekas I, Novotny J, Fabian P, Nemecek R, Palmqvist R, Strigård K, Pecen L, Svoboda T, Gurlich R, Gunnarsson U (2019) Deficient mismatch repair as a prognostic marker in stage II colon cancer patients. Eur J Surg Oncol 45(10):1854–1861. https://doi.org/10.1016/j.ejso.2019.05.023
Gkekas I, Novotny J, Fabian P, Nemecek R, Palmqvist R, Strigård K, John S, Pecen L, Reginacova K, Gunnarsson U (2019) Mismatch repair status predicts survival after adjuvant treatment in stage II colon cancer patients. J Surg Oncol 121:392–401. https://doi.org/10.1002/jso.25798
Auclin E, André T, Taieb J, Banzi M, Van Laethem JL, Tabernero J, Hickish T, de Gramont A, Vernerey D (2019) Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial. Br J Cancer 121(4):312–317. https://doi.org/10.1038/s41416-019-0521-7
Huang L, Jansen L, Balavarca Y, van der Geest L, Lemmens V, Groot Koerkamp B, van Santvoort HC, Grützmann R, Besselink MG, Schrotz-King P, Brenner H (2019) Significance of examined lymph node number in accurate staging and long-term survival in resected stage I-II pancreatic cancer-more is better? A large international population-based cohort study. Ann Surg. https://doi.org/10.1097/sla.0000000000003558
Liang W, He J, Shen Y, Shen J, He Q, Zhang J, Jiang G, Wang Q, Liu L, Gao S, Liu D, Wang Z, Zhu Z, Ng CS, Liu CC, Horsleben Petersen R, Rocco G, D'Amico T, Brunelli A, Chen H, Zhi X, Liu B, Yang Y, Chen W, Zhou Q, He J (2017) Impact of examined lymph node count on precise staging and long-term survival of resected non-small-cell lung cancer: a population study of the US SEER Database and a Chinese Multi-Institutional Registry. J Clin Oncol 35(11):1162–1170. https://doi.org/10.1200/jco.2016.67.5140
Zhu X, Zhao M, Zhou L, Zhang M, Cao P, Tao L (2020) Significance of examined lymph nodes number and metastatic lymph nodes ratio in overall survival and adjuvant treatment decision in resected laryngeal carcinoma. Cancer Med 9:3006–3014. https://doi.org/10.1002/cam4.2902
Tsai HL, Huang CW, Chen CW, Yeh YS, Ma CJ, Wang JY (2016) Survival in resected stage ii colorectal cancer is dependent on tumor depth, vascular invasion, postoperative CEA level, and the number of examined lymph nodes. World J Surg 40(4):1002–1009. https://doi.org/10.1007/s00268-015-3331-y
Trepanier M, Erkan A, Kouyoumdjian A, Nassif G, Albert M, Monson J, Lee L (2019) Examining the relationship between lymph node harvest and survival in patients undergoing colectomy for colon adenocarcinoma. Surgery 166(4):639–647. https://doi.org/10.1016/j.surg.2019.03.027
Ahmed S, Leis A, Chandra-Kanthan S, Fields A, Zaidi A, Abbas T, Le D, Reeder B, Pahwa P (2016) Regional lymph nodes status and ratio of metastatic to examined lymph nodes correlate with survival in stage IV colorectal cancer. Ann Surg Oncol 23(7):2287–2294. https://doi.org/10.1245/s10434-016-5200-9
Pyo JS, Shin YM, Kang DW (2019) Prognostic implication of metastatic lymph node ratio in colorectal cancers: comparison depending on tumor location. J Clin Med 8(11). https://doi.org/10.3390/jcm8111812
Wang Y, Zhou M, Yang J, Sun X, Zou W, Zhang Z, Zhang J, Shen L, Yang L, Zhang Z (2019) Increased lymph node yield indicates improved survival in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Cancer Med 8(10):4615–4625. https://doi.org/10.1002/cam4.2372
Hong T, Cai D, Jin L, Zhang Y, Lu T, Hua D, Wu X (2020) Development and validation of a nomogram to predict survival after curative resection of nonmetastatic colorectal cancer. Cancer Med 9:4126–4136. https://doi.org/10.1002/cam4.3010
Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA (2007) Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 99(6):433–441. https://doi.org/10.1093/jnci/djk092
Cai Y, Cheng G, Lu X, Ju H, Zhu X (2020) The re-evaluation of optimal lymph node yield in stage II right-sided colon cancer: is a minimum of 12 lymph nodes adequate? Int J Color Dis 35(4):623–631. https://doi.org/10.1007/s00384-019-03483-z
Chen SL, Bilchik AJ (2006) More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg 244(4):602–610. https://doi.org/10.1097/01.sla.0000237655.11717.50
Peeples C, Shellnut J, Wasvary H, Riggs T, Sacksner J (2010) Predictive factors affecting survival in stage II colorectal cancer: is lymph node harvesting relevant? Dis Colon Rectum 53(11):1517–1523. https://doi.org/10.1007/DCR.0b013e3181f20116
Vather R, Sammour T, Kahokehr A, Connolly AB, Hill AG (2009) Lymph node evaluation and long-term survival in stage II and stage III colon cancer: a national study. Ann Surg Oncol 16(3):585–593. https://doi.org/10.1245/s10434-008-0265-8
Del Paggio JC, Peng Y, Wei X, Nanji S, MacDonald PH, Krishnan Nair C, Booth CM (2017) Population-based study to re-evaluate optimal lymph node yield in colonic cancer. Br J Surg 104(8):1087–1096. https://doi.org/10.1002/bjs.10540
Tsai HL, Lu CY, Hsieh JS, Wu DC, Jan CM, Chai CY, Chu KS, Chan HM, Wang JY (2007) The prognostic significance of total lymph node harvest in patients with T2-4N0M0 colorectal cancer. J Gastrointest Surg 11(5):660–665. https://doi.org/10.1007/s11605-007-0119-x
Lemmens VE, van Lijnschoten I, Janssen-Heijnen ML, Rutten HJ, Verheij CD, Coebergh JW (2006) Pathology practice patterns affect lymph node evaluation and outcome of colon cancer: a population-based study. Ann Oncol 17(12):1803–1809. https://doi.org/10.1093/annonc/mdl312
Reinbach DH, McGregor JR, Murray GD, O'Dwyer PJ (1994) Effect of the surgeon's specialty interest on the type of resection performed for colorectal cancer. Dis Colon Rectum 37(10):1020–1023. https://doi.org/10.1007/bf02049316
Zheng YZ, Li XQ, Wang JY, Yang H, Wen J, Zhai WY, Yuan LX, Fu SS, Liao HY, Fu JH (2020) Impact of examined lymph node count for oesophageal squamous cell carcinoma in patients who underwent left transthoracic oesophagectomy. Eur J Surg Oncol 46:1956–1962. https://doi.org/10.1016/j.ejso.2020.04.047
Martinez-Meehan D, Lutfi W, Dhupar R, Christie N, Baker N, Schuchert M, Luketich JD, Okusanya OT (2020) Factors associated with survival in complete pathologic response non-small cell lung cancer. Clin Lung Cancer 21:349–356. https://doi.org/10.1016/j.cllc.2020.03.003
Kano K, Yamada T, Yamamoto K, Komori K, Watanabe H, Hara K, Shimoda Y, Maezawa Y, Fujikawa H, Aoyama T, Tamagawa H, Yamamoto N, Cho H, Shiozawa M, Yukawa N, Yoshikawa T, Morinaga S, Rino Y, Masuda M, Ogata T, Oshima T (2020) Association between lymph node ratio and survival in patients with pathological stage II/III gastric cancer. Ann Surg Oncol 27:4235–4247. https://doi.org/10.1245/s10434-020-08616-1
Iasonos A, Schrag D, Raj GV, Panageas KS (2008) How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26(8):1364–1370. https://doi.org/10.1200/jco.2007.12.9791
Li Y, Zhang G, Song X, Zhao L, Güngör C, Wang D, Liu W, Huang Y, Tan F (2020) Establishment and verification of synchronous metastatic nomogram for gastrointestinal stromal tumors (GISTs): a population-based analysis. Gastroenterol Res Pract 2020:8493707–8493707. https://doi.org/10.1155/2020/8493707
Li C, Pei Q, Zhu H, Tan F, Zhou Z, Zhou Y, Li Y, Pei H (2018) Survival nomograms for stage III colorectal cancer. Medicine 97(49):e13239. https://doi.org/10.1097/md.0000000000013239
Zheng P, Lai C, Yang W, Guo J, Xiao S, Chen Z (2020) Nomogram predicting cancer-specific survival in elderly patients with stages I-III colon cancer. Scand J Gastroenterol 55(2):202–208. https://doi.org/10.1080/00365521.2020.1720280
Hu J, Li H, He T, Deng H, Gong G, Cui Y, Liu P, Ren W, Li C, Chen J, Zu X (2020) A nomogram incorporating PD-L1, NLR, and clinicopathologic features to predict inguinal lymph node metastasis in penile squamous cell carcinoma. Urol Oncol 38:641.e19–641.e29. https://doi.org/10.1016/j.urolonc.2020.04.015
Chen L, Zeng F, Yao L, Fang T, Liao M, Long J, Xiao L, Deng G (2020) Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma. Cancer Med 9(4):1451–1461. https://doi.org/10.1002/cam4.2823
Hua J, Zhang B, Xu J, Liu J, Ni Q, He J, Zheng L, Yu X, Shi S (2019) Determining the optimal number of examined lymph nodes for accurate staging of pancreatic cancer: an analysis using the nodal staging score model. Eur J Surg Oncol 45(6):1069–1076. https://doi.org/10.1016/j.ejso.2019.01.018
Dienstmann R, Villacampa G, Sveen A, Mason MJ, Niedzwiecki D, Nesbakken A, Moreno V, Warren RS, Lothe RA, Guinney J (2019) Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer. Ann Oncol 30(10):1622–1629. https://doi.org/10.1093/annonc/mdz287
Zhang CM, Lv JF, Gong L, Yu LY, Chen XP, Zhou HH, Fan L (2016) Role of deficient mismatch repair in the personalized management of colorectal cancer. Int J Environ Res Public Health 13(9). https://doi.org/10.3390/ijerph13090892
Acknowledgments
We thank Darleny Lizardo (Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Centre, Pittsburgh) for critically reading the manuscript. The authors acknowledge the efforts of the Surveillance, Epidemiology, and End Results (SEER) Program in the creation and maintenance of the SEER database (https://seer.cancer.gov/).
Funding
This work was supported by the China Scholarship Council (201806370121).
Author information
Authors and Affiliations
Contributions
Xiangping Song and Di Xie carried out the concept and designed the study. Xiangping Song, Di Xie, and Lingling Tong had the responsibility for the integrity and accuracy of data analysis. Di Xie and Xiangping Song wrote the manuscript and all the authors approved the final version.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical statement
SEER is a publicly available database with anonymized data; no ethical review was required.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
ESM 1
(DOCX 44 kb).
Fig. S1:
Inadequate ELN is associated with inferior prognosis of stage II patients with different age ranges. (A, D) Among patients with age ≤ 60, those with smaller ELN numbers had both worse cause-specific and overall survival. (B, E) Among patients with age range from 61 to 79, those with smaller ELN numbers had both worse cause-specific and overall survival. (C, F) Among patients with age ≥ 80, those with smaller ELN numbers had both worse cause-specific and overall survival. (DOCX 2844 kb).
Rights and permissions
About this article
Cite this article
Xie, D., Song, X. & Tong, L. Stage migration resulting from inadequate number of examined lymph nodes impacts prognosis in stage II colon cancer after radical surgery. Int J Colorectal Dis 36, 959–969 (2021). https://doi.org/10.1007/s00384-020-03794-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-020-03794-6